Clinical Trial Update: A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing tocilizumab versus etanercept in adults with rheumatoid arthritis and cardiovascular risk factors has completed, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Actemra (tocilizumab) (tocilizumab)
• Enbrel (Etanercept) (Etanercept)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2017-07-13